Buscar
Mostrando ítems 1-10 de 102
The role of TCD in the evaluation of acute stroke
(Wiley, 2016)
BACKGROUND:
The additional information that transcranial Doppler (TCD) can provide as part of a multimodal imaging stroke protocol in the setting of hyper acute strokes has not been evaluated.
METHODS:
Consecutive ...
Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke: The ENCHANTED trial
(Lippincott Williams & Wilkins, 2017)
BACKGROUND:
Seizures after ischemic stroke have not been well-studied. We aim to determine the frequency, determinants, and significance of early seizures after thrombolysis for acute ischemic stroke.
METHODS:
Data ...
Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke: The ENCHANTED trial
(Lippincott Williams & Wilkins, 2017)
BACKGROUND:
Seizures after ischemic stroke have not been well-studied. We aim to determine the frequency, determinants, and significance of early seizures after thrombolysis for acute ischemic stroke.
METHODS:
Data ...
Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model.
(Elsevier B.V., 2016)
BACKGROUND:
The only pharmacological treatment with proven cost-effectiveness in reducing acute ischemic stroke (AIS) associated disability is intravenous thrombolysis with recombinant tissue plasminogen activator but ...
Minimum intravenous thrombolysis utilization rates in acute ischemic stroke to achieve population effects on disability: A discrete-event simulation model.
(Elsevier B.V., 2016)
BACKGROUND:
The only pharmacological treatment with proven cost-effectiveness in reducing acute ischemic stroke (AIS) associated disability is intravenous thrombolysis with recombinant tissue plasminogen activator but ...
Thrombolysis for Acute ischemic Stroke with Recombinant Tissue Plasminogen Activator in a Chilean Public Hospital
(2011)
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...
Thrombolysis for Acute ischemic Stroke with Recombinant Tissue Plasminogen Activator in a Chilean Public Hospital
(2011)
Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...
Performance measures for in-hospital care of acute ischemic stroke in public hospitals in Chile
(BioMed Central, 2013)
Background: The aim of this study were to describe acute care of ischemic stroke patients and adherence to
performance measures, as well as the outcomes of these events, in a sample of patients treated in public hospitals
in ...
Performance measures for in-hospital care of acute ischemic stroke in public hospitals in Chile
(BioMed Central, 2013)
Background: The aim of this study were to describe acute care of ischemic stroke patients and adherence to
performance measures, as well as the outcomes of these events, in a sample of patients treated in public hospitals
in ...
Head position and cerebral blood flow in acute ischemic stroke patients: protocol for the pilot phase, cluster randomized, Head Position in Acute Ischemic Stroke Trial (HeadPoST pilot)
(Sage Publications, 2016)
RATIONALE:
Few proven interventions exist for acute ischemic stroke (AIS), and most are expensive and restricted in applicability. Lying flat 'head down' positioning of AIS patients has been shown to increase by as much ...